Actinomycosis

For patient information click here

Actinomycosis
A patient with Actinomycosis on the right side of the face.
ICD-10	A42
ICD-9	039
DiseasesDB	145
MeSH	D000196

Actinomycosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Actinomycosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Actinomycosis On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Actinomycosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Actinomycosis
CDC on Actinomycosis
Actinomycosis in the news
Blogs on Actinomycosis
to Hospitals Treating Actinomycosis
Risk calculators and risk factors for Actinomycosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords: Actinomyces; actinomyces israeli;

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

• Actinomyces species including A. israeli

• Preferred regimen: Penicillin 3-4 million units IV q4h for 2-6 weeks THEN Penicillin V 2-4 g/day PO qid for 6-12 months
• Alternative regimen (1): Erythromycin 500-1000 mg IV q6h OR 500 mg PO qid
• Alternative regimen (2): Tetracyclin 500 mg PO qid
• Alternative regimen (3): Doxycycline 100 mg IV q12h OR 100 mg PO bid
• Alternative regimen (4): Clindamycin 900 mg IV q8h OR 300-450 mg PO qd
• Alternative regimen (5): Minocycline 100 mg IV q12h OR 100 mg PO bid

Acknowledgements

The content on this page was first contributed by: Dr. Steve Wiviott

References

Template:Bacterial diseases